We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medical House | LSE:MLH | London | Ordinary Share | GB0009246835 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.25 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMLH RNS Number : 5927Z J.M. Finn & Co 24 September 2009 FORM 8.1 DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS (Rules 8.1(a) and (b)(i) of the Takeover Code) 1. KEY INFORMATION +------------------------------------+------------------------------------------------------+ | Name of person dealing (Note 1) | J. M. FINN & CO LIMITED | +------------------------------------+------------------------------------------------------+ | Company dealt in | MEDICAL HOUSE | +------------------------------------+------------------------------------------------------+ | Class of relevant security to | ORDINARY GBP 0.01 | | which the dealings being disclosed | | | relate (Note 2) | | +------------------------------------+------------------------------------------------------+ | Date of dealing | 23rd September 2009 | +------------------------------------+------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a)Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +------------------------------------+--------------------------+----------------------------+ | | Long | Short | +------------------------------------+--------------------------+----------------------------+ | | Number (%) | Number (%) | +------------------------------------+--------------------------+----------------------------+ | (1) Relevant securities | 0 0% | | | | | | +------------------------------------+--------------------------+----------------------------+ | (2) Derivatives (other than | | | | options) | | | | | | | +------------------------------------+--------------------------+----------------------------+ | (3) Options and agreements to | | | | purchase/sell | | | | | | | +------------------------------------+--------------------------+----------------------------+ | Total | 0 0% | | | | | | +------------------------------------+--------------------------+----------------------------+ (b)Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +------------------------------------+--------------------------+----------------------------+ | Class of relevant security: | Long | Short | | | | | +------------------------------------+--------------------------+----------------------------+ | | Number (%) | Number (%) | +------------------------------------+--------------------------+----------------------------+ | (1) Relevant securities | | | | | | | +------------------------------------+--------------------------+----------------------------+ | (2) Derivatives (other than | | | | options) | | | | | | | +------------------------------------+--------------------------+----------------------------+ | (3) Options and agreements to | | | | purchase/sell | | | | | | | +------------------------------------+--------------------------+----------------------------+ | Total | | | | | | | +------------------------------------+--------------------------+----------------------------+ (c) Rights to subscribe (Note 3) +------------------------------------+------------------------------------------------------+ | Class of relevant security: | Details | | | | +------------------------------------+------------------------------------------------------+ | | | +------------------------------------+------------------------------------------------------+ 3. DEALINGS (Note 4) (a)Purchases and sales +------------------------------+-----------------------------+-------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | +------------------------------+-----------------------------+-------------------------------+ | SALE | 268,500 | 26p | | | | | +------------------------------+-----------------------------+-------------------------------+ (b)Derivatives transactions (other than options) +-----------------+--------------------+----------------------------+-------------------------+ | Product name, | Long/short (Note | Number of securities (Note | Price per unit (Note 5) | | e.g. CFD | 6) | 7) | | +-----------------+--------------------+----------------------------+-------------------------+ | | | | | +-----------------+--------------------+----------------------------+-------------------------+ (c) Options transactions in respect of existing securities (i)Writing, selling, purchasing or varying +-----------------+--------------+-----------------+----------+------------+---------+---------------+ | Product name, | Writing, | Number of | Exercise | Type, e.g. | Expiry | Option money | | e.g. call | selling, | securities to | price | American, | date | paid/received | | option | purchasing, | which the | | European | | per unit | | | varying etc. | option relates | | etc. | | (Note 5) | | | | (Note 7) | | | | | +-----------------+--------------+-----------------+----------+------------+---------+---------------+ | | | | | | | | +-----------------+--------------+-----------------+----------+------------+---------+---------------+ (ii)Exercising +------------------------------+-----------------------------+-------------------------------+ | Product name, e.g. call | Number of securities | Exercise price per unit (Note | | option | | 5) | +------------------------------+-----------------------------+-------------------------------+ | | | | +------------------------------+-----------------------------+-------------------------------+ (d)Other dealings (including new securities) (Note 4) +------------------------------+-----------------------------+-------------------------------+ | Nature of transaction (Note | Details | Price per unit (if | | 8) | | applicable) (Note 5) | | | | | +------------------------------+-----------------------------+-------------------------------+ | | | | +------------------------------+-----------------------------+-------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +------------------------------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding between the person | | disclosing and any other person relating to the voting rights of any relevant securities | | under any option referred to on this form or relating to the voting rights or future | | acquisition or disposal of any relevant securities to which any derivative referred to | | on this form is referenced. If none, this should be stated. | +------------------------------------------------------------------------------------------+ | | +------------------------------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9)YES/NO +---------------------------------------------------+---------------------------------------+ | Date of disclosure | 24th September 2009 | +---------------------------------------------------+---------------------------------------+ | Contact name | MITESH PATEL | +---------------------------------------------------+---------------------------------------+ | Telephone number | 0203 207 3325 | +---------------------------------------------------+---------------------------------------+ | Name of offeree/offeror with which associated | MEDICAL HOUSE | +---------------------------------------------------+---------------------------------------+ | Specify category and nature of associate | CONNECTED ADVISOR | | status (Note 10) | | +---------------------------------------------------+---------------------------------------+ Notes The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange END DCCEAPNLADPNEEE
1 Year Medical House Chart |
1 Month Medical House Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions